Fragment-Based Drug Discovery: Difference between revisions
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
<s></s>Paclitaxel in Apoptosis | <s></s>Paclitaxel in Apoptosis | ||
<StructureSection load='1ysi' size='500' side='right' caption='Structure of HMG-CoA reductase (PDB entry [[1ysi]])' scene=''> | <StructureSection load='1ysi' size='500' side='right' caption='Structure of HMG-CoA reductase (PDB entry [[1ysi]])' scene=''> | ||
This represents the binding of the anti-cancer drug, paclitaxel, to the anti-apoptotic protein, Bcl-xl. The protein includes six alpha helices and no beta sheets. | This represents the binding of the anti-cancer drug, paclitaxel, to the anti-apoptotic protein, Bcl-xl. The protein includes six alpha helices and no beta sheets. | ||
Bcl-xl is a protein that is over-expressed in many forms of cancers and is an initiator of tumor formation. There is also evidence that Bcl-xl expression may also contribute to chemo-resistance. | Bcl-xl is a protein that is over-expressed in many forms of cancers and is an initiator of tumor formation. There is also evidence that Bcl-xl expression may also contribute to chemo-resistance. Paclitaxel has been show to effectively inhibit the over-expression of this protein thereby inducing tumor regression and increasing chemo-sensitivity. | ||
Shown here is the interaction between paclitaxel and the protein via <scene name='Sandbox_reserved_394/Hydrogen_bonds/7'>hydrogen bond</scene>. The hydrogen bond is formed between an oxygen from the sulfoxone portion of the drug to an "N-H" group of a glycine amino acid. | Shown here is the interaction between paclitaxel and the protein via <scene name='Sandbox_reserved_394/Hydrogen_bonds/7'>hydrogen bond</scene>. The hydrogen bond is formed between an oxygen from the sulfoxone portion of the drug to an "N-H" group of a glycine amino acid. This forms one of the intermolecular or "weak" bonds between the drug and protein. | ||
Shown here is the <scene name='Sandbox_reserved_394/Hydrophobic_bonding/7'>hydrophobic bonding</scene> formed between the protein and a hydrophobic portion of paclitaxel. | Shown here is the <scene name='Sandbox_reserved_394/Hydrophobic_bonding/7'>hydrophobic bonding</scene> formed between the protein and a hydrophobic portion of paclitaxel. This is another example of the intermolecular forces that are at work. | ||
</StructureSection> | </StructureSection> | ||
Revision as of 05:37, 24 September 2012
Paclitaxel in Apoptosis
This represents the binding of the anti-cancer drug, paclitaxel, to the anti-apoptotic protein, Bcl-xl. The protein includes six alpha helices and no beta sheets.
Bcl-xl is a protein that is over-expressed in many forms of cancers and is an initiator of tumor formation. There is also evidence that Bcl-xl expression may also contribute to chemo-resistance. Paclitaxel has been show to effectively inhibit the over-expression of this protein thereby inducing tumor regression and increasing chemo-sensitivity.
Shown here is the interaction between paclitaxel and the protein via . The hydrogen bond is formed between an oxygen from the sulfoxone portion of the drug to an "N-H" group of a glycine amino acid. This forms one of the intermolecular or "weak" bonds between the drug and protein.
Shown here is the formed between the protein and a hydrophobic portion of paclitaxel. This is another example of the intermolecular forces that are at work. |
| ||||||||||